Legionella pneumophila and Staphylococcus aureus co-infections in a patient with SARS-CoV-2.
BMJ Case Rep
; 15(3)2022 Mar 01.
Article
in English
| MEDLINE | ID: covidwho-1723594
ABSTRACT
A man fully mRNA-vaccinated against COVID-19 presented to our hospital with an acute febrile illness, respiratory symptoms and a positive test for SARS-CoV-2. He was later found early into hospitalisation to have two morbid bacterial co-infections Legionella pneumophila serogroup 1 and methicillin-resistant Staphylococcus aureus (MRSA). Although this patient was initially admitted for COVID-19 management, his initial presentation was remarkable for lobar pneumonia, hyponatraemia and rhabdomyolysis more compatible with Legionnaire's disease than severe COVID-19. On discovery of MRSA pneumonia as a second bacterial infection, immunosuppressive COVID-19 therapies were discontinued and targeted antibiotics towards both bacterial co-infections were initiated. The patient's successful recovery highlighted the need to have high suspicion for bacterial co-infections in patients presenting with community-acquired pneumonia and a positive SARS-CoV-2 test, as patients with serious bacterial co-infections may have worse outcomes with use of immunosuppressive COVID-19 therapies.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Staphylococcal Infections
/
Legionella pneumophila
/
Community-Acquired Infections
/
Methicillin-Resistant Staphylococcus aureus
/
Coinfection
/
COVID-19
Type of study:
Case report
/
Diagnostic study
Topics:
Long Covid
/
Vaccines
Limits:
Humans
/
Male
Language:
English
Year:
2022
Document Type:
Article
Affiliation country:
Bcr-2021-248536
Similar
MEDLINE
...
LILACS
LIS